Variant report
Variant | nsv874089 |
---|---|
Chromosome Location | chr2:52042513-52096257 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:16)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:16 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:52063384..52066305-chr2:52068038..52070794,3 | K562 | blood: | |
2 | chr2:52063384..52066305-chr2:52068038..52070794,3 | K562 | blood: | |
3 | 2:51664217-51674289..2:52043909-52049825 | H1-hESC | embryonic stem cell: | embryo |
4 | 2:51745267-51754233..2:52043624-52043909 | K562 | blood: | |
5 | chr2:52045177..52047313-chr2:52049220..52051486,2 | K562 | blood: | |
6 | 2:52043909-52049825..2:52049825-52050373 | K562 | blood: | |
7 | chr2:52069239..52070064-chr8:36656303..36657160,2 | MCF-7 | breast: | |
8 | chr2:52045177..52047313-chr2:52049220..52051486,2 | K562 | blood: | |
9 | 2:51664217-51674289..2:52034460-52043624 | GM12878 | blood: | |
10 | chr2:52045177..52047183-chr2:52049220..52051220,2 | K562 | blood: | |
11 | chr11:63952383..63953021-chr2:52077502..52078002,2 | Hela-S3 | cervix: | |
12 | 2:51664217-51674289..2:52055539-52058793 | H1-hESC | embryonic stem cell: | embryo |
13 | chr2:52045177..52047183-chr2:52049220..52051220,2 | K562 | blood: | |
14 | chr2:52013693..52015857-chr2:52040010..52042547,2 | K562 | blood: | |
15 | 2:51755125-51764739..2:52034460-52043624 | K562 | blood: | |
16 | 2:52043909-52049825..2:52049825-52050373 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CHAC2-4 | chr2:52088587-52088626 | ENSG00000231918.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000168439 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7603003 | chr2:52042513-52042514 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs147711312 | chr2:52042527-52042528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs10638971 | chr2:52042659-52042660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs33913392 | chr2:52042660-52042661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs66807206 | chr2:52042663-52042664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs67770767 | chr2:52042682-52042683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs55662872 | chr2:52042685-52042686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs192383662 | chr2:52042692-52042693 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs571352314 | chr2:52042786-52042787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs28968772 | chr2:52042787-52042788 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs7591096 | chr2:52042788-52042789 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs201211052 | chr2:52042798-52042799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183780290 | chr2:52042814-52042815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs377533640 | chr2:52042827-52042828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs114880698 | chr2:52042842-52042843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555935683 | chr2:52042853-52042854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570408549 | chr2:52042861-52042862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574103050 | chr2:52042881-52042882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187999566 | chr2:52042884-52042885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs191394752 | chr2:52042913-52042914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs562684323 | chr2:52042916-52042917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs10192876 | chr2:52042921-52042922 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs552837996 | chr2:52042970-52042971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs182845981 | chr2:52042987-52042988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs142433310 | chr2:52043020-52043021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs111455515 | chr2:52043025-52043026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs527601271 | chr2:52043061-52043062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs187185960 | chr2:52043107-52043108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs6745103 | chr2:52043114-52043115 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs1125610 | chr2:52043134-52043135 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs553449424 | chr2:52043182-52043183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs34390039 | chr2:52043194-52043195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs556185081 | chr2:52043216-52043217 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs5831192 | chr2:52043271-52043272 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541779519 | chr2:52043273-52043274 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs397783074 | chr2:52043279-52043280 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs191644650 | chr2:52043287-52043288 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs28949916 | chr2:52043289-52043290 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs71411557 | chr2:52043310-52043311 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs554466140 | chr2:52043312-52043313 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs397844432 | chr2:52043314-52043315 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs1125611 | chr2:52043315-52043316 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs193283003 | chr2:52043330-52043331 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs150933302 | chr2:52043331-52043332 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs543475573 | chr2:52043368-52043369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs556417047 | chr2:52043397-52043398 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs534509536 | chr2:52043403-52043404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs529771024 | chr2:52043405-52043406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs368832021 | chr2:52043410-52043411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs28966389 | chr2:52043445-52043446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:52039600-52043400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr2:52043200-52044000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr2:52043200-52044600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr2:52043400-52044800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr2:52043600-52044600 | Enhancers | H1 Cell Line | embryonic stem cell |
6 | chr2:52043600-52044600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr2:52043600-52044600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr2:52043800-52044400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr2:52044200-52044600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr2:52051800-52054000 | Enhancers | Hela-S3 | cervix |
11 | chr2:52052800-52053800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr2:52053400-52054200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr2:52053800-52054200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr2:52054200-52055000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr2:52054200-52068600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr2:52071200-52072200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
17 | chr2:52071400-52072000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
18 | chr2:52071400-52072200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
19 | chr2:52071600-52072200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
20 | chr2:52071600-52072200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |